Trial intelligence / Profile preview

Rylomine for Post-Bunionectomy Pain

NCT00388011Phase 2Completed

Sponsor
Javelin Pharmaceuticals
Start
Jan 2005
Primary completion
Aug 2005
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of morphine intranasal in postoperative pain (6 arms), sponsored by Javelin Pharmaceuticals. Primary endpoint: Total Pain Relief 0-4 hours. Started Jan 2005; status: completed.

02

Drugs

morphine intranasal
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00388011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00388011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call